TickerFactsScreenerDevelopers

Aptevo Therapeutics Inc. (APVO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $3.59M2015: $4.64M2016: $9.68M2017: $7.09M2018: $30.64M2019: $12.45M2020: $39.98M2021: $45.04M2022: $22.64M2023: $16.90M2024: $8.71M2025: $21.62M$21.62M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$21.62M+148.1%
2024$8.71M-48.5%
2023$16.90M-25.3%
2022$22.64M-49.7%
2021$45.04M+12.7%
2020$39.98M+221.2%
2019$12.45M-59.4%
2018$30.64M+331.8%
2017$7.09M-26.7%
2016$9.68M+108.7%
2015$4.64M+29.1%
2014$3.59M—